Axin2 coupled excessive Wnt‐glycolysis signaling mediates social defect in autism spectrum disorders
EMBO Molecular Medicine · 07.06.2023 · 15 (6)
DOI: 10.15252/emmm.202217101 ↗Kurz gefasst
Fachartikel in der Zeitschrift EMBO Molecular Medicine, online erschienen am 20.04.2023. Verfasst von Mengmeng Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology and Institute of Neurosciences, School of Basic Medicine, Fourth Military Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Autism Spectrum Disorder. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shaanxi Key R&D Program, The Ministry of Science and Technology of China.
Abstract (Originalsprache)
Social dysfunction is the core syndrome of autism spectrum disorder (ASD) and lacks effective medicine. Although numerous risk genes and relevant environmental factors have been identified, the convergent molecular mechanism underlying ASD‐associated social dysfunction remains largely elusive. Here, we report aberrant activation of canonical Wnt signaling and increased glycolysis in the anterior cingulate cortex (ACC, a key brain region of social function) of two ASD mouse models ( Shank3 −/− and valproic acid‐treated mice) and their corresponding human neurons. Overexpressing β‐catenin in the ACC of wild‐type mice induces both glycolysis and social deficits. Suppressing glycolysis in ASD mice partially rescued synaptic and social phenotype. Axin2, a key inhibitory molecule in Wnt signaling, interacts with the glycolytic enzyme enolase 1 (ENO1) in ASD neurons. Surprisingly, an Axin2 stabilizer, XAV939, effectively blocked Axin2/ENO1 interaction, switched glycolysis/oxidative phosphorylation balance, promoted synaptic maturation, and rescued social function. These data revealed excessive neuronal Wnt‐glycolysis signaling as an important underlying mechanism for ASD synaptic deficiency, indicating Axin2 as a potential therapeutic target for social dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology and Institute of Neurosciences, School of Basic Medicine, Fourth Military Medical University, Xi'an, China.
- School of Life Science and Research Center for Natural Peptide Drugs, Shaanxi Engineering and Technological Research Center for Conversation and Utilization of Regional Biological Resources, Yanan University, Yanan, Chi…
- State Key Laboratory of Military Stomatology and National Clinical Research Center for Oral Diseases and Shaanxi Engineering Research, Center for Dental Materials and Advanced Manufacture, Department of Anesthesiology,…
ORCID-Profile: Chao Xu, Honghui Mao, Han Meng, Yazhou Wang, Shengxi Wu
Förderung
- National Natural Science Foundation of China
- Shaanxi Key R&D Program
- The Ministry of Science and Technology of China
Zitieren
APA
Wang, M., Xian, P., Zheng, W., Li, Z., Chen, A., Xiao, H., Xu, C., Wang, F., Mao, H., Meng, H., Zhao, Y., Luo, C., Wang, Y., & Wu, S. (2023). Axin2 coupled excessive Wnt‐glycolysis signaling mediates social defect in autism spectrum disorders. EMBO Molecular Medicine, 15(6). https://doi.org/10.15252/emmm.202217101
Vancouver
Wang M, Xian P, Zheng W, Li Z, Chen A, Xiao H, et al. Axin2 coupled excessive Wnt‐glycolysis signaling mediates social defect in autism spectrum disorders. EMBO Molecular Medicine. 2023;15(6). doi:10.15252/emmm.202217101
BibTeX
@article{Wang2023,
author = {Wang, Mengmeng and Xian, Panpan and Zheng, Weian and Li, Zhenzhen and Chen, Andi and Xiao, Haoxiang and Xu, Chao and Wang, Fei and Mao, Honghui and Meng, Han and Zhao, Youyi and Luo, Ceng and Wang, Yazhou and Wu, Shengxi},
title = {Axin2 coupled excessive Wnt‐glycolysis signaling mediates social defect in autism spectrum disorders},
journal = {EMBO Molecular Medicine},
year = {2023},
volume = {15},
number = {6},
doi = {10.15252/emmm.202217101}
}
EUVIMED